Carl Zeiss Meditec AG (CZMWF)
OTCMKTS
· Delayed Price · Currency is USD
55.55
-11.69 (-17.39%)
Jun 25, 2025, 8:00 PM EDT
Carl Zeiss Meditec AG Revenue
Carl Zeiss Meditec AG had revenue of 560.02M EUR in the quarter ending March 31, 2025, with 18.62% growth. This brings the company's revenue in the last twelve months to 2.17B, up 5.21% year-over-year. In the fiscal year ending September 30, 2024, Carl Zeiss Meditec AG had annual revenue of 2.07B, down -1.11%.
Revenue (ttm)
2.17B EUR
Revenue Growth
+5.21%
P/S Ratio
2.49
Revenue / Employee
378.61K EUR
Employees
5,730
Market Cap
5.85B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 2.07B | -23.17M | -1.11% |
| Sep 30, 2023 | 2.09B | 186.46M | 9.80% |
| Sep 30, 2022 | 1.90B | 256.05M | 15.55% |
| Sep 30, 2021 | 1.65B | 311.33M | 23.31% |
| Sep 30, 2020 | 1.34B | -123.87M | -8.49% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
Carl Zeiss Meditec AG News
- 22 days ago - Carl Zeiss: The Results After 6M25 Are Encouraging For 2025-2027E - Seeking Alpha
- 6 weeks ago - Carl Zeiss Meditec AG (CZMWF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Carl Zeiss Meditec: Recovery Seems Clear Enough - Seeking Alpha
- 4 months ago - Q1 2025 Carl Zeiss Meditec AG Earnings Call Transcript - GuruFocus
- 7 months ago - Carl Zeiss: Why I Am So Positive - Seeking Alpha
- 9 months ago - My 3 Favorite European Stocks To Diversify Your Portfolio - Seeking Alpha
- 10 months ago - Carl Zeiss: Significant Underperformance, Valuation At Multi-Year Lows - Seeking Alpha
- 11 months ago - Carl Zeiss Meditec AG (CZMWF) Q3 2024 Earnings Call Transcript - Seeking Alpha